Will Gibbs
Healthtech Partner at Octopus Ventures
Will Gibbs
Healthtech Partner at Octopus Ventures
Greater London, England
Overview
Work Experience
Partner
2013 - Current
Leading the Health team at Octopus Ventures - one of the most active multi-stage investors in Europe with over 150 portfolio companies and investing $1-200m per year in new investments.
Investor Representative
2024
The UK's leading D2C multi-condition digital clinic
Investor Representative/NED
2020
A leading digital health business addressing harmful addictions Octopus led the Series A round in 2020. The Series B was led by Kinnevik in 2021. The Series C was led by Atomico (Growth) in 2023. The company has raised $130m+ in funding to date.
Investor Representative/NED
2019
Skin and Me is a leading D2C subscription health company tackling acne and other medical skin care challenges. Octopus led the Seed round in 2019. The Company has raised £18.3m in funding to date.
Investor Representative/NED
2022
Inflow is one of the first fully-integrated remote clinics for ADHD Octopus led the Series A in 2022. The Company has raised $14m in funding to date
Investor Representative/NED
2015 - 2024
Permutive is a real-time data management platform, hosted on the edge - powering many of the leading global digital publishers data science companies Octopus led the Seed round in 2015. Subsequent rounds have been led by EQT and Softbank. The Company has raised $105m in funding to date.
Investor representative/NED
2021 - 2023
LVNDR is building an overdue remote digital clinic dedicated to LGBTQ health needs Octopus led the pre-seed round in 2021
Investor Representative/NED
2020 - 2023
AI powered cancer diagnostics in digital pathology Octopus co-led the Series B in 2021 and the subsequent Series C was led by 83North. The company has raised $120m in funding to date.
Investor representative/NED
2018 - 2023
Delivering delicious, handmade plant-based food to homes across the UK. Octopus led the Series A round in 2018
Board Observer/Investor Representative
2020 - 2022
Flexible cell and gene therapy manufacturing platform for cancer treatment
Education
Classical Archaeology and Ancient History
2008 - 2011